IL6R and amyotrophic lateral sclerosis: Results showed a significant (p < 0.001) increase of IL-6R immunoexpression in ECs by exposure to ALS plasma (Figure 1B,D) vs. plasma from control patient (Figure 1C,D) or FBS (Figure 1A,D).